Status:
COMPLETED
Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty
Lead Sponsor:
Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions:
Coronary Angioplasty
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Aim of the study is to evaluate the benefits from adjunctive intracoronary administration of adenosin in elective patients undergoing coronary angioplasty.
Detailed Description
This study will investigate the effects of adjunctive intracoronary administration of adenosine on periprocedural myocardial infarction as compared to placebo. This is a double-blind randomized trial...
Eligibility Criteria
Inclusion
- Patients undergoing elective coronary angioplasty
Exclusion
- Marked Bradycardia (\< 40 bpm)
- Previous allergy to adenosine
- Inability to sign the informed consent
- Asthma
- Elevated cardiac enzymes (troponin I o CK-MB)
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT01148147
Start Date
November 1 2009
End Date
August 1 2010
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Giuseppe De Luca
Novara, Italy, 28100